Work

Perspective on This Article from The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

Year: 2023

Type: other

Abstract: Perspective on This Article from The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

DOI: 10.1158/1940-6207.22524780

Authors: Altaf Mohammed, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele, Chinthalapally V. Rao

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362530422

Cites:

Cited by:

Related to: 10